1. Home
  2. STTK vs SBFG Comparison

STTK vs SBFG Comparison

Compare STTK & SBFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$4.76

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Logo SB Financial Group Inc.

SBFG

SB Financial Group Inc.

HOLD

Current Price

$21.06

Market Cap

134.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
SBFG
Founded
2016
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
119.0M
134.8M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
STTK
SBFG
Price
$4.76
$21.06
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
626.6K
12.9K
Earning Date
11-06-2025
01-29-2026
Dividend Yield
N/A
2.90%
EPS Growth
N/A
21.17
EPS
N/A
2.11
Revenue
$1,000,000.00
$63,406,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$10.14
Revenue Growth
N/A
11.76
52 Week Low
$0.69
$17.10
52 Week High
$4.89
$24.48

Technical Indicators

Market Signals
Indicator
STTK
SBFG
Relative Strength Index (RSI) 75.73 48.29
Support Level $4.09 $20.90
Resistance Level $4.89 $21.56
Average True Range (ATR) 0.34 0.72
MACD 0.07 -0.14
Stochastic Oscillator 89.50 30.48

Price Performance

Historical Comparison
STTK
SBFG

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About SBFG SB Financial Group Inc.

SB Financial Group Inc that provides a range of community banking services, including commercial and consumer lending, personal and business banking, treasury management and merchant services, personal wealth management and brokerage services, and other financial services to individuals, businesses, and municipalities. It operates in single segment which is Banking.

Share on Social Networks: